Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study
about
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysisClinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis.18F-Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography Imaging of Metastatic Nasopharyngeal Cancer with Emphasis on the Distribution of Bone Metastases.Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.Prognostic value of nodal SUVmax of 18F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort Study.Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2- Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study
P2860
Q28077401-D0E29928-A6A0-45B4-9014-79903EB5CF7AQ33719906-976965AB-92E0-435B-9454-40AB0DE8975AQ33767652-8E9689F3-013D-4D92-98EB-32139800CE6FQ38818668-59447E0F-711B-4CD7-80FC-B42A18253DB2Q38836743-07B02FB5-D520-4D47-8864-3E4F60E883B6Q38909224-4B19E062-E76E-4B16-AF2A-859498E9DC99Q40539372-659DC395-929D-45B8-9307-6D266B467441Q42360793-C178EE81-A60E-4C5C-87A3-520C1C46A506Q48095788-C588E5FC-6D17-4778-AB1A-6A3D3DA740B3Q50062208-4BF954CA-8A3F-4349-B8DC-8C55946602DDQ50894106-07E55695-DD23-4B27-9536-F2496E9E8B44Q52576030-6777D525-F437-4ADE-99C7-0095E0BD76D8Q59129064-E696E132-299E-4725-9094-168F70797AFA
P2860
Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@ast
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@en
type
label
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@ast
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@en
prefLabel
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@ast
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@en
P2093
P2860
P1433
P1476
Pretreatment (18)F-FDG uptake ...... rcinoma--a retrospective study
@en
P2093
Beiling Zhu
Herong Pan
Yingjian Zhang
Yongping Zhang
Zhifeng Yao
Zhongyi Yang
P2860
P2888
P356
10.1186/S13014-014-0268-5
P577
2015-01-08T00:00:00Z
P5875
P6179
1016533253